Rodríguez-Vallejo JM - Search Results

1

Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression.

Sáez C, González-Baena AC, Japón MA, Giráldez J, Segura DI, Miranda G, Rodríguez-Vallejo JM, González-Esteban J, Torrubia F. Sáez C, et al. Prostate. 1998 Oct 1;37(2):84-90. doi: 10.1002/(sici)1097-0045(19981001)37:2<84::aid-pros4>3.0.co;2-l. Prostate. 1998. PMID: 9759702

2

Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.

Sáez C, González-Baena AC, Japón MA, Giráldez J, Segura DI, Rodríguez-Vallejo JM, González-Esteban J, Miranda G, Torrubia F. Sáez C, et al. Among authors: rodriguez vallejo jm. Prostate. 1999 Jul 1;40(2):83-8. doi: 10.1002/(sici)1097-0045(19990701)40:2<83::aid-pros3>3.0.co;2-n. Prostate. 1999. PMID: 10386468

3

[Morphologic course of prostatic hyperplasia].

Algaba Arrea F, Trias I, López L, Rodríguez-Vallejo JM, González Esteban J. Algaba Arrea F, et al. Among authors: rodriguez vallejo jm. Actas Urol Esp. 2000 Jun;24(6):463-7. doi: 10.1016/s0210-4806(00)72484-3. Actas Urol Esp. 2000. PMID: 11011428 Spanish.

4

Neuroendocrine cells in peripheral prostatic zone: age, prostatic intraepithelial neoplasia and latent cancer-related changes.

Algaba F, Trias I, Lopez L, Rodriguez-Vallejo JM, Gonzalez-Esteban J. Algaba F, et al. Eur Urol. 1995;27(4):329-33. doi: 10.1159/000475191. Eur Urol. 1995. PMID: 7656912

5

[Relationship of prostatic carcinoma of the peripheral zone with glandular atrophy and prostatic intraepithelial neoplasia].

Algaba Arrea F, Trias Puig-Sureda I, López Duesa L, Rodríguez-Vallejo JM, González-Esteban J. Algaba Arrea F, et al. Actas Urol Esp. 1997 Jan;21(1):40-3. Actas Urol Esp. 1997. PMID: 9182444 Spanish.

6

Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependent EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride.

Schwartz S Jr, Caceres C, De Torres I, Morote J, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Int J Cancer. 1998 May 18;76(4):519-22. doi: 10.1002/(sici)1097-0215(19980518)76:4<519::aid-ijc13>3.0.co;2-2. Int J Cancer. 1998. PMID: 9590128

7

Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older.

Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Chicharro-Molero JA, et al. J Urol. 1998 Mar;159(3):878-82. doi: 10.1097/00005392-199803000-00072. J Urol. 1998. PMID: 9474174

8

Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.

Schwartz S Jr, Caceres C, Morote J, De Torres I, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Int J Cancer. 1998 May 18;76(4):464-7. doi: 10.1002/(sici)1097-0215(19980518)76:4<464::aid-ijc3>3.0.co;2-p. Int J Cancer. 1998. PMID: 9590118

9

[Prevalence of prostatic intraepithelial neoplasia in Spain].

Sánchez Chapado M, Angulo J, Cabeza M, Donat E, Ruiz A, Olmedilla G, Rodríguez Vallejo JM. Sánchez Chapado M, et al. Among authors: rodriguez vallejo jm. Arch Esp Urol. 2001 Dec;54(10):1103-9. Arch Esp Urol. 2001. PMID: 11852518 Spanish.

10

[Interpretation of results of clinical trials in benign prostatic hyperplasia].

Millán Rodríguez F, Rodríguez Vallejo JM, Carballido Rodríguez J. Millán Rodríguez F, et al. Among authors: rodriguez vallejo jm. Actas Urol Esp. 2002 Jan;26(1):4-14. doi: 10.1016/s0210-4806(02)72721-6. Actas Urol Esp. 2002. PMID: 11899738 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters